U.S. commits $4 billion to international COVAX vaccine alliance

President Biden today told a group of G-7 leaders that the U.S. will support the COVAX alliance tasked with distributing COVID-19 vaccines to 92 low- and middle-income countries.
The program is co-administered by the World Health Organization and international vaccine alliance Gavi. The U.S.-contributed funds includes $2 billion appropriated by Congress in December, with an additional $2 billion through 2021 and 2022. The program’s goal is to vaccinate 20% of people living in the 92 target countries.
Related News Articles
Headline
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…
Headline
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…